Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Save
103107 50 µg ¥7,920
103108 500 µg ¥19,650
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  3. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  4. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  5. Sefik E, et al. 2022. Nature. 606:585. PubMed
  6. Leinroth AP, et al. 2022. Cell Rep. 39:110785. PubMed
  7. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  8. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  9. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  10. Tao X, et al. 2022. EMBO J. 41:e110439. PubMed
  11. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  12. Li X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1077. PubMed
  13. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  14. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  15. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  16. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  17. Zheng Z, et al. 2022. Cells. 11: . PubMed
  18. Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed
  19. Varshney R, et al. 2023. iScience. 26:105750. PubMed
  20. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  21. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  22. Chen L, et al. 2023. Bioeng Transl Med. 8:e10377. PubMed
  23. Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed
  24. Zhao Y, et al. 2023. Sci Adv. 9:eabo1360. PubMed
  25. Liu X, et al. 2022. Pain. 163:508. PubMed
  26. González H, et al. 2022. Cell. 185:729. PubMed
  27. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  28. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  29. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  30. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  31. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  32. Pfeifhofer-Obermair C, et al. 2022. Bio Protoc. 12:e4378. PubMed
  33. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  34. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  35. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  36. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  37. Hanuscheck N, et al. 2022. J Exp Med. 219:. PubMed
  38. Klawitter M, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  40. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  41. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  42. Zhang Y, et al. 2023. Invest Ophthalmol Vis Sci. 64:1. PubMed
  43. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  44. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  45. Li M, et al. 2023. Front Immunol. 14:1087923. PubMed
  46. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  47. Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed
  48. Volkova MV, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Li L, et al. 2023. iScience. 26:106095. PubMed
  51. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  52. Xu H, et al. 2023. Acta Pharm Sin B. 13:678. PubMed
  53. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  54. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  55. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  56. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  57. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  58. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  59. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  60. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  61. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  62. Wang X, et al. 2023. Nature. 618:808. PubMed
  63. Akasaka H, et al. 2023. JCI Insight. 8:. PubMed
  64. Duquesne, P., Aoun, C., et al. 2025. Sci Adv. 11(42),eadx7672. PubMed
  65. Zhang, X., Ji, Z., et al. 2025. Mater Today Bio. 34(0),102166. PubMed
  66. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  67. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  68. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  69. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  70. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  71. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  72. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  73. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  74. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  75. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  76. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  77. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  78. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  79. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  80. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  81. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  82. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  83. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  84. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  85. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  86. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  87. Zhu H, et al. 2018. Elife. 7:. PubMed
  88. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  89. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  90. Saito S, et al. 2020. Nutrients. 12:. PubMed
  91. Liu X, et al. 2020. Nature. . PubMed
  92. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  93. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  94. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  95. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  96. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  97. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  98. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  99. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  100. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  101. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  102. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  103. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  104. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  105. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  106. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  107. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  108. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  109. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  110. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  111. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  112. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  113. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  114. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  115. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  116. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  117. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  118. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  119. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  120. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  121. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  122. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  123. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  124. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  125. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  126. Zhang X, et al. 2022. Cells. 11:. PubMed
  127. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  128. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  129. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  130. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  131. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  132. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  133. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  134. Plein A, et al. 2018. Nature. 562:223. PubMed
  135. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  136. Green DP, et al. 2019. Neuron. 101:412. PubMed
  137. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  138. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  139. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  140. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  141. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  142. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  143. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  144. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  145. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  146. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  147. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  148. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  149. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  150. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  151. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  152. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  153. Li J, et al. 2020. Elife. 9:00. PubMed
  154. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  155. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  156. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  157. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  158. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  159. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  160. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  161. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  162. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  163. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  164. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  165. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  166. Wan X, et al. 2018. Nature. 560:107. PubMed
  167. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  168. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  169. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  170. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  171. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  172. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  173. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  174. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  175. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  176. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  177. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  178. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  179. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  180. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  181. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  182. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  183. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  184. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  185. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  186. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  187. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  188. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  189. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  190. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  191. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  192. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  193. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  194. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  195. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  196. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  197. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  198. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  199. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  200. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  201. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  202. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  203. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  204. Long JT, et al. 2022. Elife. 11:. PubMed
  205. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  206. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  207. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  208. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  209. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  210. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  211. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  212. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  213. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  214. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  215. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  216. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  217. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  218. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  219. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  220. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  221. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  222. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  223. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  224. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  225. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  226. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  227. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  228. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  229. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  230. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  231. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  232. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  233. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  234. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  235. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  236. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  237. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  238. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  239. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  240. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  241. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  242. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  243. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  244. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  245. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  246. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  247. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  248. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  249. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  250. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  251. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  252. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  253. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  254. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  255. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  256. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  257. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  258. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  259. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  260. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  261. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  262. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  263. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  264. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  265. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  266. Sheng J, et al. 2021. eLife. 10:00. PubMed
  267. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  268. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  269. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  270. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  271. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  272. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  273. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  274. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  275. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  276. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  277. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  278. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  279. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  280. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  281. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  282. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  283. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  284. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  285. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  286. Dingler FA, et al. 2020. Mol Cell. . PubMed
  287. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  288. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  289. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  290. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  291. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  292. Wolf Y, et al. 2019. Cell. 179:219. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 665 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account